Kaye I Foster-Cheek's Net Worth
$14.4 Million
Who is Kaye I Foster-Cheek?
Kaye I Foster-Cheek has an estimated net worth of $14.4 Million. This is based on reported shares across multiple companies, which include JOHNSON & JOHNSON, AGIOS PHARMACEUTICALS, INC., Prime Medicine, Inc., and ONYX PHARMACEUTICALS INC.
SEC CIK
Kaye I Foster-Cheek's CIK is 0001312622
Past Insider Trading and Trends
2009 was Kaye I Foster-Cheek's most active year for acquiring shares with 11 total transactions. Kaye I Foster-Cheek's most active month to acquire stocks was the month of January. 2013 was Kaye I Foster-Cheek's most active year for disposing of shares, totalling 25 transactions. Kaye I Foster-Cheek's most active month to dispose stocks was the month of July. 2009 saw Kaye I Foster-Cheek paying a total of $5,522,458.28 for 193,662 shares, this is the most they've acquired in one year. In 2009 Kaye I Foster-Cheek cashed out on 201,719 shares for a total of $6,393,157.08, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
JOHNSON & JOHNSON (JNJ) Snapshot price: $164.4
VP, Human Resources
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +2.96% | 34 |
—
|
—
| 1.18K |
Dec 31
| |||
Form 4
| +0.01% | 8 |
$60.06 | -$742,553.64 | 124.58K |
Nov 30 - Dec 10
| |||
Form 4
| +0.80% | 9 |
—
|
—
| 1.14K |
Sep 30
| |||
Form 4
| +11.77% | 119 |
—
|
—
| 1.13K |
Jun 30
| |||
Form 4
| +8.24% | 77 |
—
|
—
| 1.01K |
Mar 31
| |||
Form 4
| +565.02% | 3.76K |
$57.31 | -$128,145.16 | 4.43K |
Feb 12 - Feb 13
| |||
Form 4
| +3.43% | 31 |
—
|
—
| 934 |
Jan 30 - Feb 9
| |||
Form 4
| +0.86% | 8 |
—
|
—
| 936 |
Dec 31
| |||
Form 4
| +2.54% | 23 |
—
|
—
| 928 |
Sep 30
| |||
Form 4
| +8.51% | 71 |
—
|
—
| 905 |
May 30 - Jun 30
| |||
Form 4
| +7.61% | 59 |
—
|
—
| 834 |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
| +3.47% | 26 |
—
|
—
| 775 |
Jan 31 - Feb 11
| |||
Form 4
| +0.67% | 5 |
—
|
—
| 749 |
Dec 31
| |||
Form 4
| +0.54% | 4 |
—
|
—
| 744 |
Jun 29 - Sep 28
| |||
Form 4
| +19.16% | 119 |
—
|
—
| 740 |
Jun 29
| |||
Form 4
| +4.72% | 28 |
—
|
—
| 621 |
Feb 28 - Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
| +4.22% | 24 |
—
|
—
| 593 |
Jan 31 - Feb 12
| |||
Form 4
| -0.25% | -3.00 |
—
|
—
| 1.2K |
Dec 19 - Dec 29
| |||
Form 4
| +0.89% | 5 |
—
|
—
| 566 |
Sep 29
| |||
Form 4
| +20.91% | 97 |
—
|
—
| 561 |
Jun 30
| |||
Form 4
| +12.90% | 53 |
—
|
—
| 464 |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
| +56.87% | 149 |
—
|
—
| 411 |
Jan 31 - Feb 13
| |||
Form 4
| +83.19% | 396 |
—
|
—
| 872 |
Jan 31 - Feb 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AGIOS PHARMACEUTICALS, INC. (AGIO) Snapshot price: $43.28
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| -3.19% | -176.00 |
—
|
—
| 5.35K |
Jun 13
| |||
Form 4
| -18.87% | -1.28K |
$31.62 | -$40,631.70 | 5.52K |
Mar 7
| |||
Form 4
| -40.91% | -4.71K |
$32.00 | -$150,898.85 | 6.81K |
Mar 5 - Mar 6
| |||
Form 4
|
—
|
0
|
$22.03 | -$196,637.50 | 11.52K |
Aug 9
| |||
Form 4
| +75.97% | 4.97K |
—
|
—
| 11.52K |
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
| -25.15% | -2.20K |
—
|
—
| 6.55K |
Jan 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
| +22.12% | 1.58K |
—
|
—
| 8.75K |
May 20
| |||
Form 4
| +30.78% | 1.69K |
—
|
—
| 7.16K |
May 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
| +52.17% | 1.88K |
—
|
—
| 5.48K |
May 28 - May 29
| |||
Form 4
| +63.64% | 1.4K |
—
|
—
| 3.6K |
May 29 - May 31
| |||
Form 4
|
—
|
0
|
$72.14 | -$385,356.32 | 2.2K |
Scheduled
|
Jun 14
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
—
|
0
|
$64.65 | -$235,552.00 | 2.2K |
Scheduled
|
Mar 19
| ||
Form 4
|
∞
| 2.2K |
$47.33 | $104,126.00 | 2.2K |
Feb 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Prime Medicine, Inc. (PRME) Snapshot price: $3.4303
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ONYX PHARMACEUTICALS INC No price found
SVP, Global Human Resources
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -27.07K |
$125.00 | -$3,383,250.00 |
0
|
Oct 1
| |||
Form 4
|
—
|
0
|
$81.98 | -$902,505.51 | 27.07K |
Scheduled
|
Aug 6
| ||
Form 4
|
—
|
0
|
$60.50 | -$520,947.47 | 27.07K |
Scheduled
|
May 7
| ||
Form 4
| -12.40% | -3.83K |
$87.75 | -$336,344.44 | 27.07K |
Scheduled
|
Apr 1 - Apr 2
| ||
Form 4
| +21.18% | 5.4K |
—
|
—
| 30.9K |
Mar 28
| |||
Form 4
|
—
|
0
|
$52.74 | -$718,467.92 | 25.5K |
Scheduled
|
Feb 15
| ||
Form 4
| -8.40% | -2.34K |
$56.79 | -$359,878.80 | 25.5K |
Nov 6
| |||
Form 4
| -6.75% | -2.02K |
$85.08 | -$171,436.20 | 27.84K |
Scheduled
|
Oct 2
| ||
Form 4
| -17.15% | -7.47K |
$50.30 | -$1,416,845.41 | 36.1K |
Aug 6
| |||
Form 4
| -5.09% | -2.33K |
$73.97 | -$172,723.92 | 43.57K |
Scheduled
|
Jul 25
| ||
Form 4
| +64.47% | 18K |
$36.58 | -$18,470.98 | 45.91K |
Scheduled
|
Mar 30 - Apr 2
| ||
Form 4
| -9.70% | -3.00K |
$34.97 | -$585,832.00 | 27.91K |
Dec 5
| |||
Form 4
| -4.94% | -1.60K |
$29.75 | -$47,749.55 | 30.91K |
Scheduled
|
Oct 3
| ||
Form 4
| -5.19% | -1.78K |
$30.00 | -$53,434.63 | 32.52K |
Scheduled
|
Sep 23
| ||
Form 4
| +92.70% | 16.5K |
—
|
—
| 34.3K |
Mar 31
| |||
Form 4
|
∞
| 17.8K |
—
|
—
| 17.8K |
Sep 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||